Acute Kidney Injury (AKI) in the Newborn
1. Overview
Neonatal AKI is a common and serious condition - occurring in up to 38% of NICU admissions, and in up to 40% of neonates with associated comorbidities (e.g., perinatal asphyxia, sepsis, CHD). It is associated with increased mortality, prolonged hospital stay, and long-term risk of chronic kidney disease (CKD).
The newborn kidney is inherently vulnerable because:
- GFR is very low at birth and matures slowly over weeks
- Tubular function is immature (poor ability to concentrate/dilute urine, obligate sodium losses)
- The kidney cannot efficiently handle excess fluid, electrolytes, or nephrotoxins
2. Definition (Modified KDIGO for Neonates)
AKI is defined by rise in serum creatinine (SCr) OR fall in urine output:
Important neonatal caveat: At birth, neonatal SCr reflects maternal creatinine (normally ~0.8-1.0 mg/dL). It physiologically falls over the first 7-14 days to a nadir of ~0.3-0.4 mg/dL in term infants (lower in preterm). Therefore, a rising SCr in the first days of life - even if the absolute value is "normal" - is abnormal and suggests AKI.
KDIGO Staging for Neonates
| Stage | Serum Creatinine Criteria | Urine Output Criteria |
|---|
| 1 | Rise ≥0.3 mg/dL in 48 hrs OR ≥1.5x baseline in 7 days | <1.0 mL/kg/hr for 6-12 hrs |
| 2 | ≥2.0x baseline | <0.5 mL/kg/hr for ≥12 hrs |
| 3 | ≥3.0x baseline OR SCr ≥2.5 mg/dL | <0.3 mL/kg/hr for ≥24 hrs OR anuria ≥12 hrs |
3. Causes - The Three Categories
A. Prerenal (Most Common, ~70%)
Reduced kidney perfusion - kidney structure is intact
- Hypovolemia (fluid losses, hemorrhage, dehydration)
- Perinatal asphyxia / hypoxia-ischemia (HI)
- Sepsis / septic shock
- Cardiac failure / congenital heart disease (CHD)
- Patent ductus arteriosus (PDA) - reduces renal perfusion
- Necrotizing enterocolitis (NEC)
- High mean airway pressure (impairs venous return)
- Twin-to-twin transfusion syndrome (donor twin)
- ECMO
B. Intrinsic Renal (Intrinsic damage to kidney parenchyma)
- Acute tubular necrosis (ATN) - most common intrinsic cause; follows prolonged prerenal or nephrotoxin exposure
- Nephrotoxic medications: aminoglycosides (gentamicin), vancomycin, NSAIDs (indomethacin, ibuprofen - close PDA but impair renal blood flow), amphotericin B, acyclovir, contrast agents
- Renal vein thrombosis (presents with hematuria, thrombocytopenia, flank mass)
- Congenital renal anomalies (polycystic kidney disease, renal dysplasia)
- Perinatal asphyxia - direct tubular ischemic injury
C. Postrenal (Obstructive)
- Posterior urethral valves (PUV) - most common obstructive cause, males only
- Ureteropelvic junction (UPJ) obstruction
- Bilateral hydronephrosis
- Urethral atresia, prune belly syndrome
4. Risk Factors for Neonatal AKI
| Category | Examples |
|---|
| Prematurity / low birth weight | VLBW (<1500 g), ELBW (<1000 g) |
| Perinatal events | Asphyxia, Apgar <6 at 5 min |
| Infections | Sepsis, congenital infections |
| Structural | Congenital heart disease, renal anomalies |
| Drugs | Aminoglycosides, NSAIDs, vancomycin, ACE inhibitors (maternal) |
| Procedures | Cardiac surgery, ECMO |
| Metabolic | Hyperuricemia (tumor lysis), hemolysis |
5. Clinical Features
- Oliguria - urine output <1 mL/kg/hr (most sensitive early sign); anuria may be present
- Edema - periorbital, peripheral, or generalized; fluid overload
- Hypertension - due to fluid/sodium retention
- Electrolyte abnormalities:
- Hyperkalemia (dangerous - can cause arrhythmias)
- Hyponatremia (dilutional)
- Hyperphosphatemia
- Hypocalcemia
- Metabolic acidosis
- Elevated SCr and BUN (azotemia)
- Signs of underlying cause - pallor (sepsis), respiratory distress, abdominal distension (NEC/obstruction)
6. Investigations
| Test | Purpose |
|---|
| Serum creatinine (daily) | Define and stage AKI |
| BMP (Na, K, Cl, HCO3, BUN, Cr) | Electrolytes + acid-base |
| Calcium, phosphate | Metabolic effects |
| Urine output (strict I/O, daily weights) | Monitor function |
| Urine analysis (dipstick + microscopy) | Hematuria → thrombosis/glomerular; casts → ATN |
| Urine Na, FENa | Distinguish prerenal vs intrinsic |
| Renal ultrasound | Structural anomalies, obstruction, vascular Doppler |
| Blood gas | Metabolic acidosis severity |
| CBC, cultures | Sepsis workup |
FENa (Fractional Excretion of Sodium) in Neonates
- FENa = (urine Na × plasma Cr) ÷ (plasma Na × urine Cr) × 100
- Prerenal: FENa <2-3% in term; <5% in preterm
- Intrinsic ATN: FENa >3% in term; >5% in preterm
- (Note: FENa is normally higher in preterm neonates due to immature tubular reabsorption - interpret carefully)
7. Management
Step 1 - Treat the Underlying Cause
- Restore perfusion (fluid resuscitation for prerenal) - isotonic bolus 10-20 mL/kg over 30-60 min
- Treat sepsis (antibiotics - choose least nephrotoxic regimen)
- Relieve obstruction (urinary catheter, urology consult for PUV)
- Stop nephrotoxic drugs
Step 2 - Fluid Management
- If hypovolemic (prerenal): fluid challenge 10-20 mL/kg isotonic saline or LR
- If euvolemic/hypervolemic (intrinsic/established AKI): fluid restrict to insensible losses (~30-50 mL/kg/day) + urine output replacement only
- Strict input/output records and daily weights are mandatory
- Avoid fluid overload - it is independently associated with mortality
Step 3 - Electrolyte Management
| Problem | Treatment |
|---|
| Hyperkalemia (K+ >6.5 mEq/L or ECG changes) | Stop K+ intake; calcium gluconate (cardiac stabilization); sodium bicarbonate; glucose + insulin; kayexalate (sodium polystyrene) - use cautiously in neonates due to NEC risk; dialysis if refractory |
| Hyponatremia | Fluid restrict (dilutional); replace only if symptomatic |
| Metabolic acidosis | Sodium bicarbonate if pH <7.2 or HCO3 <12 |
| Hypocalcemia | IV calcium gluconate |
| Hyperphosphatemia | Phosphate binders (calcium carbonate with feeds) |
Step 4 - Nutritional Support
- Ensure adequate caloric intake despite fluid restriction
- Adjust formula concentration or TPN
- Dietitian consultation for fluid-restricted neonates
Step 5 - Drug Dose Adjustment
- All renally-cleared drugs must have doses/intervals adjusted
- Aminoglycosides: extend dosing interval, monitor drug levels
- Avoid NSAIDs, contrast agents, nephrotoxic combinations
Step 6 - Dialysis / Renal Replacement Therapy (RRT)
Indications:
- Severe refractory hyperkalemia
- Fluid overload unresponsive to diuretics
- Severe metabolic acidosis
- Uremic symptoms (encephalopathy, pericarditis)
- SCr ≥2.5 mg/dL persistent
Modalities in neonates:
- Peritoneal dialysis (PD) - first choice in most neonatal centers; catheter inserted surgically; well-tolerated even in small/preterm infants
- Continuous renal replacement therapy (CRRT) - for hemodynamically unstable neonates; requires specialized equipment and vascular access; used in larger/more stable NICUs
- Hemodialysis is rarely used in neonates due to technical difficulty
8. Diuretics in Neonatal AKI
- Furosemide: often used to convert oliguric to non-oliguric AKI and to manage fluid overload
- Does NOT improve outcomes or reduce need for dialysis - used for fluid management, not to treat AKI itself
- Dose: 1-2 mg/kg IV; can be given as continuous infusion in severe fluid overload
- Use only after adequate volume status is confirmed (not in prerenal AKI)
9. When to Consult Nephrology
- AKI stage 2-3 (KDIGO)
- SCr ≥2.5 mg/dL persisting beyond 3 days
- Need for dialysis
- Suspected structural renal anomaly
- Refractory electrolyte disturbances
10. Prognosis and Follow-up
- Most prerenal AKI resolves with treatment of the underlying cause
- ATN may take days to weeks to recover
- Long-term risk: neonatal AKI - even if resolved - is associated with:
- CKD in childhood and adulthood
- Hypertension
- Reduced nephron mass (especially in preterm)
- Recommended follow-up:
- 3-6 months post-discharge for AKI requiring dialysis
- 6-12 months for preterm/SGA infants with severe AKI (SCr ≥2.5 mg/dL)
- Annual BP and creatinine checks thereafter
Sources: National Kidney Foundation Primer on Kidney Diseases 8e; Barash Clinical Anesthesia 9e; Canadian Paediatric Society AKI Guidelines (2024); Newborn Critical Care Center AKI Clinical Guidelines (reviewed March 2024); KDIGO AKI Framework